Oxygen Therapy for Pneumonia in Children: WHO Guidelines, Devices, and Thresholds

Pneumonia kills more children under five than any other infectious disease worldwide, and oxygen therapy is the single most critical intervention for children with severe pneumonia-related hypoxemia. The World Health Organization estimates that pneumonia accounts for 14% of all deaths in children under 5, killing approximately 740,000 children annually. In many of these cases, death results not from the infection itself but from the resulting oxygen deprivation. Appropriate oxygen delivery, at the right flow rate, through the right device, guided by pulse oximetry, saves lives.¹

This guide covers WHO guidelines for childhood pneumonia oxygen therapy, SpO2 thresholds for initiating treatment, delivery devices sized for children, when to escalate care, and the challenges of oxygen access in low-resource settings.

WHO Classification of Childhood Pneumonia

The WHO classifies childhood pneumonia severity to guide treatment decisions, including when to start oxygen therapy:

Classification	Key Signs	Oxygen Needed?	Setting
Non-severe pneumonia	Fast breathing only (no chest indrawing)	No (unless SpO2 < 90%)	Outpatient
Severe pneumonia	Chest indrawing, SpO2 < 90%, inability to drink	Yes	Hospital
Very severe pneumonia	Central cyanosis, severe respiratory distress, danger signs	Yes, high-flow or CPAP	Hospital / ICU

Fast breathing thresholds by age:¹

• Under 2 months: 60 breaths per minute or more
• 2-12 months: 50 breaths per minute or more
• 1-5 years: 40 breaths per minute or more

SpO2 Thresholds: When to Start Oxygen

Pulse oximetry is the cornerstone of oxygen therapy decisions in children. WHO recommends starting oxygen when SpO2 drops below 90%. Some national guidelines and clinical contexts use different thresholds:

Guideline	Start Oxygen At	Target SpO2
WHO (low-resource)	SpO2 < 90%	90-96%
BTS (British Thoracic Society)	SpO2 < 92%	94-98%
AAP / US practice	SpO2 < 90-92%	94-98%
Preterm neonates	SpO2 < 88-90%	88-95% (to prevent ROP)

Importantly, clinical signs alone are unreliable for detecting hypoxemia in children. A study by Laman et al. found that clinical assessment missed hypoxemia in 29% of children with pneumonia who had SpO2 below 90%.⁵ Cyanosis, the most recognized clinical sign, does not appear until SpO2 drops below approximately 80-85%, and is difficult to detect in children with dark skin.

“Pulse oximetry is not optional in childhood pneumonia management. Clinical signs alone miss nearly one-third of hypoxemic children. Where pulse oximeters are unavailable, mortality from pneumonia is significantly higher.”
Duke et al., 2008, Archives of Disease in Childhood

Oxygen Delivery Devices for Children

Nasal Prongs (Nasal Cannula)

Nasal prongs are the preferred first-line oxygen delivery device for infants and children with moderate hypoxemia. They are simple, allow feeding and interaction, and are well-tolerated by most children.

Age Group	Flow Rate	Approximate FiO2
Neonates	0.25-0.5 L/min	25-35%
Infants (1-12 months)	0.5-1 L/min	25-40%
Toddlers (1-3 years)	1-2 L/min	28-45%
Children (3-12 years)	1-4 L/min	28-50%

Important: Maximum recommended flow rate via nasal prongs in children is 2 L/min for infants and 4 L/min for older children. Higher flows cause nasal irritation, gastric distension, and discomfort without significant FiO2 improvement.²

Head Box (Oxygen Hood)

A head box is a clear plastic enclosure placed over the infant’s head that fills with oxygen-enriched air. It is used primarily for neonates and small infants who do not tolerate nasal prongs.

• Flow rate: 5-10 L/min (to prevent CO2 accumulation)
• FiO2: 30-90% (adjustable, should be measured with an oxygen analyzer)
• Best for: Neonates in NICUs, infants requiring precise FiO2 without nasal interfaces
• Limitations: Infant must remain still, limits access for feeding and procedures

Face Mask

Pediatric face masks are available in various sizes but are generally less well-tolerated than nasal prongs in young children. They are used when higher FiO2 is needed than nasal prongs can provide but CPAP is not indicated.

• Flow rate: 4-8 L/min (minimum 4 L/min to prevent rebreathing)
• FiO2: 35-60%
• Best for: Short-term use, procedural sedation, transition from higher to lower support

Bubble CPAP

Bubble CPAP (continuous positive airway pressure) has been one of the most significant advances in pediatric respiratory care in low-resource settings. The system uses nasal prongs connected to a water seal that creates a constant positive pressure, keeping alveoli open during exhalation.

Parameter	Typical Setting
CPAP pressure	5-8 cmH2O
Flow rate	5-10 L/min
FiO2	21-60% (blended oxygen and air)
Cost of equipment	$300-500 (improvised systems even less)

A landmark trial by Chisti et al. (2015) showed that bubble CPAP reduced mortality by 75% compared to low-flow oxygen alone in children under 5 with severe pneumonia and hypoxemia. The trial was stopped early due to the overwhelming benefit.³

High-Flow Nasal Cannula (HFNC)

HFNC is increasingly used in pediatric settings, delivering heated and humidified oxygen at higher flow rates than standard nasal prongs:

• Neonates: 2-8 L/min
• Infants: 4-15 L/min (approximately 2 L/kg/min)
• Children: Up to 2 L/kg/min (max 50 L/min in adolescents)

HFNC provides some CPAP effect (2-5 cmH2O), washes out nasopharyngeal dead space, and is better tolerated than CPAP by many children. It has been shown to reduce intubation rates in bronchiolitis and is increasingly studied for pneumonia.⁶

Hospital vs. Outpatient Management

WHO guidelines recommend hospitalization and oxygen therapy for children with:¹

• SpO2 below 90% (or below 92% in some guidelines)
• Severe chest indrawing
• Inability to feed or drink
• Altered consciousness, convulsions, or danger signs
• Age under 2 months with any pneumonia diagnosis

Outpatient management with oral antibiotics is appropriate for non-severe pneumonia in children who can feed, have SpO2 above 92%, and can be reliably followed up within 48-72 hours.

When to Escalate

Escalation from standard oxygen to advanced respiratory support should occur when:

Sign	Action
SpO2 remains < 90% on nasal prongs at max flow	Switch to bubble CPAP or HFNC
Increasing respiratory rate despite oxygen	Escalate to CPAP; consider ICU transfer
Worsening chest indrawing or grunting	Start CPAP if not already on it
Apneic episodes	Immediate escalation; consider intubation
Failure to improve on CPAP after 1-2 hours	Intubation and mechanical ventilation
Altered consciousness or exhaustion	Intubation regardless of SpO2

Challenges in Low-Resource Settings

The majority of childhood pneumonia deaths occur in sub-Saharan Africa and South Asia, where oxygen therapy faces significant barriers:⁴

• Pulse oximetry access: Many district hospitals and health centers lack functional pulse oximeters, making hypoxemia detection unreliable
• Oxygen supply: Cylinder-based oxygen is expensive and supply chains are unreliable. Oxygen concentrators are more sustainable but require reliable electricity
• Trained staff: Many facilities lack health workers trained in pediatric oxygen therapy, proper flow rate selection, and monitoring
• Equipment maintenance: Concentrators, flowmeters, and pulse oximeters require maintenance and calibration that is often unavailable

Organizations like PATH, WHO, and UNICEF have been working to expand oxygen access through concentrator distribution, solar-powered systems, and the Every Breath Counts coalition.⁷

Safety Considerations Specific to Children

• Preterm neonates: Keep SpO2 between 88-95% to prevent retinopathy of prematurity (ROP). Avoid targeting SpO2 above 95%.
• Monitoring frequency: Check SpO2 at least every 2-4 hours. Continuous monitoring preferred in severe cases.
• Weaning: Reduce oxygen gradually as clinical condition improves. Wean by 0.5 L/min at a time and recheck SpO2 after 15-30 minutes.
• Nasal obstruction: Young infants are obligate nasal breathers. Clear nasal secretions regularly to maintain oxygen delivery effectiveness.
• Humidification: Always humidify oxygen delivered above 2 L/min to prevent mucosal drying in children.

Bottom Line

Oxygen therapy is a life-saving intervention for childhood pneumonia when delivered appropriately. Nasal prongs are the first-line device for most children, bubble CPAP has dramatically reduced mortality in severe cases, and HFNC is an emerging alternative. Pulse oximetry should guide all oxygen therapy decisions, as clinical signs alone miss nearly a third of hypoxemic children. The biggest challenge is not knowing how to deliver oxygen therapy but ensuring that the right equipment and training reach the facilities where children are dying.

References

1. World Health Organization. “Revised WHO classification and treatment of childhood pneumonia at health facilities: evidence summaries.” Geneva: WHO; 2014. WHO Publication
2. Duke T. “CPAP: a guide for clinicians in developing countries.” Paediatrics and International Child Health, 2014;34(1):3-11. DOI: 10.1179/2046905513Y.0000000102
3. Chisti MJ, Salam MA, Smith JH, et al. “Bubble continuous positive airway pressure for children with severe pneumonia and hypoxaemia in Bangladesh: an open, randomised controlled trial.” The Lancet, 2015;386(9998):1057-1065. DOI: 10.1016/S0140-6736(15)00249-5
4. Graham H, Bakare AA, Ayede AI, et al. “Oxygen systems to improve clinical care and outcomes for children and neonates: a stepped-wedge cluster-randomised trial in Nigerian hospitals.” PLoS Medicine, 2019;16(11):e1002951. DOI: 10.1371/journal.pmed.1002951
5. Laman M, Ripa P, Vince J, Tefuarani N. “Can clinical signs predict hypoxemia in Papua New Guinean children with moderate and severe pneumonia?” Annals of Tropical Paediatrics, 2005;25(1):23-27. DOI: 10.1179/146532805X23308
6. Franklin D, Babl FE, Schlapbach LJ, et al. “A randomized trial of high-flow oxygen therapy in infants with bronchiolitis.” New England Journal of Medicine, 2018;378(12):1121-1131. DOI: 10.1056/NEJMoa1714855
7. Every Breath Counts Coalition. “Oxygen is essential: a call to action.” The Lancet Respiratory Medicine, 2019;7(3):e15-e16. DOI: 10.1016/S2213-2600(18)30515-2